Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Cash Flow Reinvestment Rate
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A cash flow reinvestment rate. Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) has a Cash Flow Reinvestment Rate of 0.19x as of December 2025, reinvesting CN¥159.70 Million (capex CN¥152.89 Million plus investments CN¥-6.81 Million) from operating cash flow of CN¥837.18 Million. Explore Anhui Huaren Health Pharmaceutical Co. L cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)
Cash flow reinvestment rate of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A from 2021 to 2025. Historical reinvestment intensity for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A across 5 annual periods. Explore 301408 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Cash Flow Reinvestment Rate by Year (2021–2025)
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A cash flow reinvestment rate by year from 2021 to 2025. Year-by-year capital reinvestment analysis for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A. For the full cash flow conversion analysis, see cash efficiency ratio of Anhui Huaren Health Pharmaceutical Co. L.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | CN¥159.70 Million | CN¥837.18 Million | CN¥152.89 Million | ▼ -32.4% |
| 2024 | 0.28x | CN¥161.29 Million | CN¥571.76 Million | CN¥160.89 Million | ▼ -87.6% |
| 2023 | 2.27x | CN¥298.08 Million | CN¥131.37 Million | CN¥216.31 Million | ▲ +225.7% |
| 2022 | 0.70x | CN¥121.08 Million | CN¥173.84 Million | CN¥104.77 Million | ▲ +89.8% |
| 2021 | 0.37x | CN¥51.68 Million | CN¥140.82 Million | CN¥33.91 Million | — |